Lipopolyplex formulation enables highly efficient siRNA transfection with significantly reduced levels of cell damage compared to cationic-liposome based transfection reagents
New transfection reagent TransIT-Siquest is said to be ideal for siRNA-mediated gene silencing studies in mammalian cells. Developed by Mirus and available from Cambridge BioScience, the unique lipopolyplex formulation enables highly efficient siRNA transfection with significantly reduced levels of cell damage compared to cationic-liposome based transfection reagents. TransIT-Siquest is most effective when carried out in complete growth media with no media changes or serum addition required, increasing convenience and saving time.
This low toxicity reagent is proven to work effectively in a wide range of cell types and complements Mirus's range which includes the popular TransIT-TKO siRNA transfection reagent.
Each formulation provides a distinct transfection profile for high efficiency, broad-spectrum siRNA delivery.
These products are available from Cambridge BioScience in the UK and Ireland only.
